Terms: = Prostate cancer AND ATP1A1, P05023, MGC51750, MGC3285, ENSG00000163399, 476 AND Treatment
41 results:
1. Secondary Primary cancer Risk After Radiation Therapy in Rectal cancer: A Population-Based Cohort Study With Propensity Score Matching.
Schlesinger-Raab A; Schubert-Fritschle G; Kim M; Werner J; Belka C; Wolff H; Agha A; Fuchs M; Friess H; Combs S; Häussler B; Engel J; Halfter K
Clin Colorectal Cancer; 2023 Dec; 22(4):485-495.e3. PubMed ID: 37838522
[TBL] [Abstract] [Full Text] [Related]
2. prostate cancer: Under-representation of African American Men in Research Studies Used in the Latest NCCN Guidelines.
Lubarsky R; Ambinder D; Barnett J; Choudhury M; Saji A; Fishman AI; Fullerton S; Phillips JL
Urology; 2023 Oct; 180():28-34. PubMed ID: 37479145
[TBL] [Abstract] [Full Text] [Related]
3. Impact of Asian Race on Prognosis in De Novo Metastatic prostate cancer.
Ni X; Luu M; Ma W; Zhang T; Wei Y; Freedland SJ; Ye D; Daskivich TJ; Zhu Y
J Natl Compr Canc Netw; 2023 Jul; 21(7):733-741.e3. PubMed ID: 37433430
[TBL] [Abstract] [Full Text] [Related]
4. Testosterone suppression plus enzalutamide versus testosterone suppression plus standard antiandrogen therapy for metastatic hormone-sensitive prostate cancer (ENZAMET): an international, open-label, randomised, phase 3 trial.
Sweeney CJ; Martin AJ; Stockler MR; Begbie S; Cheung L; Chi KN; Chowdhury S; Frydenberg M; Horvath LG; Joshua AM; Lawrence NJ; Marx G; McCaffrey J; McDermott R; McJannett M; North SA; Parnis F; Parulekar W; Pook DW; Reaume MN; Sandhu SK; Tan A; Tan TH; Thomson A; Vera-Badillo F; Williams SG; Winter D; Yip S; Zhang AY; Zielinski RR; Davis ID;
Lancet Oncol; 2023 Apr; 24(4):323-334. PubMed ID: 36990608
[TBL] [Abstract] [Full Text] [Related]
5. Strategies to improve cost effectiveness of robotic assisted laparoscopic radical prostatectomy in emerging economies.
Caicedo JI; Santander J; Taborda A; Medina C; Zuluaga L; Trujillo CG; Castillo CB; Londoño Trujillo D; Plata M
J Robot Surg; 2023 Feb; 17(1):243-250. PubMed ID: 35668314
[TBL] [Abstract] [Full Text] [Related]
6. Long-term outcomes of whole gland high-intensity focused ultrasound for localized prostate cancer.
Lo Verde K; Toledano H; Campagna J; Rossi D; Bastide C; Baboudjian M
Int Urol Nephrol; 2022 Jun; 54(6):1233-1238. PubMed ID: 35397077
[TBL] [Abstract] [Full Text] [Related]
7. Conventional dose versus dose escalated radiotherapy including high-dose-rate brachytherapy boost for patients with Gleason score 9-10 clinical localized prostate cancer.
Yamazaki H; Suzuki G; Aibe N; Shimizu D; Kimoto T; Masui K; Yoshida K; Nakamura S; Okabe H
Sci Rep; 2022 Jan; 12(1):268. PubMed ID: 34997125
[TBL] [Abstract] [Full Text] [Related]
8. Multiple Docetaxel Retreatments Without Prednisone for Metastatic Castration-Resistant prostate cancer in the Docetaxel-Only Era: Effects on PSA Kinetics and Survival.
Maj-Hes A; Szarvas T; Sevcenco S; Kramer G
Adv Ther; 2021 Jul; 38(7):3831-3841. PubMed ID: 34043207
[TBL] [Abstract] [Full Text] [Related]
9. Safety of image-guided radiotherapy in definitive radiotherapy for localized prostate cancer: a population-based analysis.
Kuo YH; Liang JA; Chen GH; Li CC; Chien CR
Br J Radiol; 2021 May; 94(1121):20200456. PubMed ID: 33861622
[TBL] [Abstract] [Full Text] [Related]
10. Patients' preferences for delaying metastatic castration-resistant prostate cancer: Combining health state and treatment valuation.
Rentz AM; Mansukhani SG; Liu J; Lloyd AJ; Heidenreich S; Matza LS; Dawson NA; Shore N; Freedland SJ
Urol Oncol; 2021 Jun; 39(6):367.e7-367.e17. PubMed ID: 33736976
[TBL] [Abstract] [Full Text] [Related]
11. Dual Blockade of c-MET and the Androgen Receptor in Metastatic Castration-resistant prostate cancer: A Phase I Study of Concurrent Enzalutamide and Crizotinib.
Tripathi A; Supko JG; Gray KP; Melnick ZJ; Regan MM; Taplin ME; Choudhury AD; Pomerantz MM; Bellmunt J; Yu C; Sun Z; Srinivas S; Kantoff PW; Sweeney CJ; Harshman LC
Clin Cancer Res; 2020 Dec; 26(23):6122-6131. PubMed ID: 32943461
[TBL] [Abstract] [Full Text] [Related]
12. Highly effective prophylaxis with ertapenem for transrectal ultrasound-guided prostate biopsy: effects on overall antibiotic use and inpatient hospital exposure.
Bloomfield MG; Wilson AD; Studd RC; Blackmore TK
J Hosp Infect; 2020 Nov; 106(3):483-489. PubMed ID: 32861740
[TBL] [Abstract] [Full Text] [Related]
13. [Individual control of urine volume to improve stability of bladder volume in radiotherapy of urinary tumor].
Wang H; Jiang SK; Peng R; Huang Y; Wang MQ; Wang JJ; Liu C; Zhang F; Ma LL
Beijing Da Xue Xue Bao Yi Xue Ban; 2020 Aug; 52(4):688-691. PubMed ID: 32773802
[TBL] [Abstract] [Full Text] [Related]
14. Comparative study of surgical orchidectomy and medical castration in treatment efficacy, adverse effects and cost based on a large prospective metastatic prostate cancer registry.
Tan YG; Poon RJ; Pang LJ; Villanueva A; Huang HH; Chen K; Ng TK; Tay KJ; Ho HS; Yuen JS
Urol Oncol; 2020 Aug; 38(8):682.e1-682.e9. PubMed ID: 32475745
[TBL] [Abstract] [Full Text] [Related]
15. Hyprofractionated Versus Conventionally Fractionated Radiation Therapy for Patients with Intermediate- or High-Risk, Localized, prostate cancer: 7-Year Outcomes From the Randomized, Multicenter, Open-Label, Phase 3 HYPRO Trial.
de Vries KC; Wortel RC; Oomen-de Hoop E; Heemsbergen WD; Pos FJ; Incrocci L
Int J Radiat Oncol Biol Phys; 2020 Jan; 106(1):108-115. PubMed ID: 31593756
[TBL] [Abstract] [Full Text] [Related]
16. The association between education and risk of major cardiovascular events among prostate cancer patients: a study from the Diet, cancer and Health study.
Moustsen IR; Friberg AS; Larsen SB; Duun-Henriksen AK; Tjønneland A; Kjaer SK; Brasso K; Johansen C; Dalton SO
Acta Oncol; 2019 May; 58(5):715-721. PubMed ID: 30757932
[No Abstract] [Full Text] [Related]
17. Survival after a cancer diagnosis among solid organ transplant recipients in the United States.
D'Arcy ME; Coghill AE; Lynch CF; Koch LA; Li J; Pawlish KS; Morris CR; Rao C; Engels EA
Cancer; 2019 Mar; 125(6):933-942. PubMed ID: 30624768
[TBL] [Abstract] [Full Text] [Related]
18. Incidence of cardiovascular disease up to 13 year after cancer diagnosis: A matched cohort study among 32 757 cancer survivors.
Schoormans D; Vissers PAJ; van Herk-Sukel MPP; Denollet J; Pedersen SS; Dalton SO; Rottmann N; van de Poll-Franse L
Cancer Med; 2018 Oct; 7(10):4952-4963. PubMed ID: 30220107
[TBL] [Abstract] [Full Text] [Related]
19. Complications of curative radiation treatment for early prostate cancer.
James M; McLean G; Williams S; Robinson B; Yi M
Asia Pac J Clin Oncol; 2018 Oct; 14(5):e392-e398. PubMed ID: 29336525
[TBL] [Abstract] [Full Text] [Related]
20. cancer Mortality, Early Detection and treatment among Adult New Zealanders: Changes in Perceptions between 2001 and 2014/5.
Richards R; McNoe B; Iosua E; Reeder AI; Egan R; Marsh L; Robertson L; Maclennan B; Latu ATF; Quigg R; Petersen AC
Asian Pac J Cancer Prev; 2017 Dec; 18(12):3401-3406. PubMed ID: 29286610
[TBL] [Abstract] [Full Text] [Related]
[Next]
